Patients on GLP-1 or GLP-1/GIP agonists had significant residual gastric volume if the medication was not held prior to upper endoscopy, unless they were on a clear liquid diet the previous day, ...

Continuing GLP-1/GIP agonist therapy prior to elective upper endoscopy increases the risk for residual gastric volume, but clear liquids the day before could mitigate the risk.

California and Florida led the nation in top-rated ASCs for colonoscopy and endoscopy, according to U.S. News’ “2026 Best Ambulatory Surgery Centers” published March 17. The 2026 U.S. News ratings for ...

Patients on GLP-1 or GLP-1/GIP agonists had significant residual gastric volume (RGV) if the medication wasn't held prior to upper endoscopy unless they were on a clear liquid diet the day before, the ...